Amikacin-Containing Self-Emulsifying Delivery Systems Via Pulmonary Administration for Treatment of Bacterial Infections of Cystic Fibrosis Patients

Gergely Hetényi1 Thiomatrix Forschungs – und Beratungs GmbHInnsbruckAustria

Janine Griesser1 Thiomatrix Forschungs – und Beratungs GmbHInnsbruckAustria

Simon Fontana1 Thiomatrix Forschungs – und Beratungs GmbHInnsbruckAustria

Anja Martinez Gutierrez1 Thiomatrix Forschungs – und Beratungs GmbHInnsbruckAustria

Helmut Ellemunter3 Cystic Fibrosis CentreDepartment of Child & Adolescent HealthPediatrics IIIMedical University of InnsbruckInnsbruckAustria

Katharina Niedermayr3 Cystic Fibrosis CentreDepartment of Child & Adolescent HealthPediatrics IIIMedical University of InnsbruckInnsbruckAustria

Péter Szabó4 University Pharmacy Department of Pharmacy AdministrationSemmelweis UniversityBudapestHungary

Andreas Bernkop-Schnürch1 Thiomatrix Forschungs – und Beratungs GmbHInnsbruckAustria;2 Department of Pharmaceutical TechnologyInstitute of PharmacyLeopold-Franzens-UniversityInnsbruckAustriaCorrespondence[email protected]

show all

Amikacin-Containing Self-Emulsifying Delivery Systems Via Pulmonary Administration for Treatment of Bacterial Infections of Cystic Fibrosis Patients

Supplemental Text 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Amikacin-Containing Self-Emulsifying Delivery Systems Via Pulmonary Administration for Treatment of Bacterial Infections of Cystic Fibrosis Patients

Supplemental Text 1

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date